발 및 발목용 재건 기기 시장 : 시장 규모, 점유율, 동향 분석 보고서 - 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Foot And Ankle Reconstruction Devices Market Summary

The global foot and ankle reconstruction devices market size was estimated at USD 1.60 billion in 2024 and is projected to reach USD 3.25 billion by 2033, growing at a CAGR of 8.23% from 2025 to 2033. The market is driven by the rising prevalence of degenerative joint diseases, trauma injuries, and deformities, along with the growing adoption of minimally invasive surgical techniques and next-generation implant systems.

Increasing geriatric and diabetic populations are contributing to a higher incidence of ankle arthritis and deformities, driving surgical demand. In September 2024, Stryker expanded its Foot & Ankle portfolio in the U.S. with the Osteotomy Truss System for foot osteotomies and the Ankle Truss System for tibiotalocalcaneal fusions and total ankle procedures.

The growing number of older adults worldwide drives the rising demand for orthopedic ankle and foot reconstruction. Osteoarthritis, degenerative joint abnormalities, and persistent foot conditions that demand surgical treatment are more common in older adults. The need for surgeries such as total ankle replacement, midfoot and hindfoot fusions, and deformity corrections is fueled by an aging population that has an increased likelihood of musculoskeletal degenerative disease. In January 2024, according to the CDC, about 33 million U.S. adults had osteoarthritis, causing joint pain, stiffness, and swelling, with a higher risk in older adults, women, those with obesity, joint injuries, or a family history.

Minimally invasive techniques enhance results and shorten recovery periods. To minimize operative trauma and hasten recovery, surgeons are increasingly employing less invasive methods for tendon reconstructions, fusions, and corrective osteotomies. In August 2025, DePuy Synthes launched the TriLEAP Lower Extremity Anatomic Plating System across the U.S., offering low-profile, procedure-specific plates for forefoot and midfoot reconstruction, bunion, and fracture fixation surgeries. The system enhances precision and customization for diverse foot anatomies.

Advances in surgical technology, such as computer-assisted navigation and preoperative planning tools, are improving precision and predictability in complex reconstructions. By improving patient outcomes and decreasing revisions, these tools assist surgeons in optimizing implant placement, alignment, and fixation. In March 2025, Paragon 28 showcased its new portfolio at the ACFAS Annual Conference, including SMART 28 Portal, APEX 3D Stemmed Tibial, Phantom Fibula Nail, R3FLEX, FJ2000, and PRECISION MIS Bunion System.

Global Foot And Ankle Reconstruction Devices Market Report Segmentation

This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global foot and ankle reconstruction devices market report based on application, end use, and region:

• Application Outlook (Revenue USD Million, 2021 - 2033)
• Hallux Valgus / Bunion Correction
• Hammertoe Correction
• Midfoot Reconstruction
• Hindfoot & Ankle Reconstruction
• Total Ankle Replacement (TAR)
• Toe Joint Replacement
• End Use Outlook (Revenue USD Million, 2021 - 2033)
• Hospitals
• Outpatient Facilities
• Specialty Orthopedic Centers
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Application outlook
  • 2.2.2. End use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Global Foot and Ankle Reconstruction Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Global Foot and Ankle Reconstruction Devices: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Case Study Analysis
• 3.5. Advancements in Foot and Ankle Care in Europe: Technology, Patient-Centric Models, and Research Innovation
  • 3.5.1. Technological Advancements in Foot & Ankle
    • 3.5.1.1. Robotics and Computer Navigation
    • 3.5.1.2. Artificial Intelligence (Ai)
    • 3.5.1.3. Advanced Imaging Techniques
    • 3.5.1.4. 3d Printing and Personalized Implants
    • 3.5.1.5. Biologics and Regenerative Medicine
    • 3.5.1.6. Minimally Invasive and Patient-Centric Care
    • 3.5.1.7. Enhanced Rehabilitation Models
    • 3.5.1.8. Digital Health and Wearables

Chapter 4. Global Foot and Ankle Reconstruction Devices Market Segment Analysis, By Application, 2021-2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Application Market Share Analysis, 2024 & 2033
• 4.3. Segment Dashboard
• 4.4. Global Foot and Ankle Reconstruction Devices Market, by Application, 2021 to 2033
• 4.5. Hallux Valgus / Bunion Correction
  • 4.5.1. Hallux valgus / bunion correction market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.6. Hammertoe Correction
  • 4.6.1. Hammertoe correction market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.7. Midfoot Reconstruction
  • 4.7.1. Midfoot reconstruction market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.8. Hindfoot & Ankle Reconstruction
  • 4.8.1. Hindfoot & ankle reconstruction market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.9. Total Ankle Replacement (TAR)
  • 4.9.1. Total ankle replacement (TAR) market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.10. Toe Joint Replacement
  • 4.10.1. Toe joint replacement market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Global Foot and Ankle Reconstruction Devices Market Segment Analysis, By End Use, 2021-2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. End Use Market Share Analysis, 2024 & 2033
• 5.3. Segment Dashboard
• 5.4. Global Foot and Ankle Reconstruction Devices Market, by End Use 2021 to 2033
• 5.5. Hospitals
  • 5.5.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD million)
• 5.6. Outpatient Facilities
  • 5.6.1. Outpatient facilities market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.7. Specialty Orthopedic Centers
  • 5.7.1. Specialty orthopedic centers market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Foot and Ankle Reconstruction Devices Market Segment Analysis, By Region, 2021- 2033 (USD Million)

• 6.1. Regional Market Share Analysis, 2024 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Regional Market Snapshot
• 6.4. Foot and Ankle Reconstruction Devices Market Share by Region, 2024 & 2033:
• 6.5. North America
  • 6.5.1. North America foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Scenario
    • 6.5.2.3. Competitive Scenario
    • 6.5.2.4. U.S. foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Scenario
    • 6.5.3.3. Competitive Scenario
    • 6.5.3.4. Canada foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Regulatory Scenario
    • 6.5.4.3. Competitive Scenario
    • 6.5.4.4. Mexico foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
• 6.6. Europe
  • 6.6.1. Europe foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
  • 6.6.2. UK
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Scenario
    • 6.6.2.3. Competitive Scenario
    • 6.6.2.4. UK foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
  • 6.6.3. Germany
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Scenario
    • 6.6.3.3. Competitive Scenario
    • 6.6.3.4. Germany foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
  • 6.6.4. France
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Scenario
    • 6.6.4.3. Competitive Scenario
    • 6.6.4.4. France foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
  • 6.6.5. Italy
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Scenario
    • 6.6.5.3. Competitive Scenario
    • 6.6.5.4. Italy foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
  • 6.6.6. Spain
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Regulatory Scenario
    • 6.6.6.3. Competitive Scenario
    • 6.6.6.4. Spain foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
  • 6.6.7. Norway
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Regulatory Scenario
    • 6.6.7.3. Competitive Scenario
    • 6.6.7.4. Norway foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1. Key Country Dynamics
    • 6.6.8.2. Regulatory Scenario
    • 6.6.8.3. Competitive Scenario
    • 6.6.8.4. Sweden foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
  • 6.6.9. Denmark
    • 6.6.9.1. Key Country Dynamics
    • 6.6.9.2. Regulatory Scenario
    • 6.6.9.3. Competitive Scenario
    • 6.6.9.4. Denmark foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key Country Dynamics
    • 6.7.1.2. Regulatory Scenario
    • 6.7.1.3. Competitive Scenario
    • 6.7.1.4. Japan foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Scenario
    • 6.7.2.3. Competitive Scenario
    • 6.7.2.4. China foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Regulatory Scenario
    • 6.7.3.3. Competitive Scenario
    • 6.7.3.4. India foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
  • 6.7.4. Australia
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Regulatory Scenario
    • 6.7.4.3. Competitive Scenario
    • 6.7.4.4. Australia foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Regulatory Scenario
    • 6.7.5.3. Competitive Scenario
    • 6.7.5.4. South Korea foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
  • 6.7.6. Thailand
    • 6.7.6.1. Key Country Dynamics
    • 6.7.6.2. Regulatory Scenario
    • 6.7.6.3. Competitive Scenario
    • 6.7.6.4. Thailand foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key Country Dynamics
    • 6.8.1.2. Regulatory Scenario
    • 6.8.1.3. Competitive Scenario
    • 6.8.1.4. Brazil foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
  • 6.8.2. Argentina
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Scenario
    • 6.8.2.3. Competitive Scenario
    • 6.8.2.4. Argentina foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. Key Country Dynamics
    • 6.9.1.2. Regulatory Scenario
    • 6.9.1.3. Competitive Scenario
    • 6.9.1.4. South Africa foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Key Country Dynamics
    • 6.9.2.2. Regulatory Scenario
    • 6.9.2.3. Competitive Scenario
    • 6.9.2.4. Saudi Arabia foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
  • 6.9.3. UAE
    • 6.9.3.1. Key Country Dynamics
    • 6.9.3.2. Regulatory Scenario
    • 6.9.3.3. Competitive Scenario
    • 6.9.3.4. UAE foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)
  • 6.9.4. Kuwait
    • 6.9.4.1. Key Country Dynamics
    • 6.9.4.2. Regulatory Scenario
    • 6.9.4.3. Competitive Scenario
    • 6.9.4.4. Kuwait foot and ankle reconstruction devices market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Profiles
  • 7.3.1. Smith+Nephew
    • 7.3.1.1. Company overview
    • 7.3.1.2. Financial performance
    • 7.3.1.3. Product benchmarking
    • 7.3.1.4. Strategic initiatives
  • 7.3.2. Arthrex, Inc.
    • 7.3.2.1. Company overview
    • 7.3.2.2. Financial performance
    • 7.3.2.3. Product benchmarking
    • 7.3.2.4. Strategic initiatives
  • 7.3.3. DePuy Synthes (Johnson & Johnson)
    • 7.3.3.1. Company overview
    • 7.3.3.2. Financial performance
    • 7.3.3.3. Product benchmarking
    • 7.3.3.4. Strategic initiatives
  • 7.3.4. CONMED Corporation
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Stryker
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Globus Medical
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Anika Therapeutics, Inc
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Zimmer Biomet
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Enovis Corp.
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Orthofix, Inc.
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. Acumed LLC.
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Product benchmarking
    • 7.3.11.4. Strategic initiatives